ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Pyxis Oncology Inc

Pyxis Oncology Inc (PYXS)

4.26
0.06
(1.43%)
At close: March 28 04:00PM
4.26
0.06
( 1.43% )
After Hours: 07:37PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
4.26
Bid
4.16
Ask
4.33
Volume
386,930
4.13 Day's Range 4.48
1.35 52 Week Range 6.92
Market Cap
Previous Close
4.20
Open
4.13
Last Trade
4
@
4.16
Last Trade Time
18:32:15
Financial Volume
$ 1,663,697
VWAP
4.2997
Average Volume (3m)
848,582
Shares Outstanding
44,323,046
Dividend Yield
-
PE Ratio
-1.56
Earnings Per Share (EPS)
-2.72
Revenue
-
Net Profit
-120.72M

About Pyxis Oncology Inc

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the ... Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Pyxis Oncology Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PYXS. The last closing price for Pyxis Oncology was $4.20. Over the last year, Pyxis Oncology shares have traded in a share price range of $ 1.35 to $ 6.92.

Pyxis Oncology currently has 44,323,046 shares outstanding. The market capitalization of Pyxis Oncology is $188.82 million. Pyxis Oncology has a price to earnings ratio (PE ratio) of -1.56.

PYXS Latest News

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...

Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights

Non-dilutive funding to support development of first-in-concept lead Antibody-Drug Conjugate (ADC) asset, PYX-201 Pyxis Oncology retains rights to three other antibodies in development by...

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023

PYX-201 Phase 1 Part 1 trial progressing with initial data expected in the fall of 2024 PYX-106 Phase 1 trial progressing with initial data expected 2H 2024 Completed $50 million private placement...

Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA

BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: β€œPYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat...

Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024

BOSTON, March 07, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...

Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting

PYX-201, an EDB+FN-specific tumor stroma-targeting ADC, demonstrates potent anti-tumor efficacy across multiple human cancers in PDX tumor models The PYX-201 target EDB+FN is found overexpressed...

Form 8-K - Current report

false000178222300017822232024-02-262024-02-26   UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.73-14.6292585174.995.23.611862974.39600352CS
4-2.24-34.46153846156.56.793.67715565.15787555CS
122.19105.7971014492.076.851.998485824.64268406CS
262.39127.8074866311.876.851.354672854.18968353CS
521.2139.67213114753.056.921.3511189984.24785176CS
156-14.74-77.578947368419191.16027794.22263236CS
260-14.74-77.578947368419191.16027794.22263236CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QLIQilian International Holding Group Ltd
$ 1.05
(52.20%)
2.87M
SBFMSunshine Biopharma Inc
$ 0.08
(32.23%)
26.44M
GRTXGalera Therapeutics Inc
$ 0.182
(30.00%)
1.34M
MEDPMedpace Holdings Inc
$ 480.00
(18.77%)
1.41k
JSPRWJasper Therapeutics Inc
$ 0.2147
(17.97%)
600
XTKGX3 Holdings Company Ltd
$ 0.655
(-33.85%)
1.37M
VVOSVivos Therapeutics Inc
$ 3.70
(-23.40%)
88.12k
NVVENuvve Holding Corporation
$ 0.87
(-20.91%)
140.13k
APLTApplied Therapeutics Inc
$ 5.70
(-16.18%)
286.63k
NDRAENDRA Life Sciences Inc
$ 0.49
(-15.52%)
153.81k
SBFMSunshine Biopharma Inc
$ 0.08
(32.23%)
26.44M
CRKNCrown Electrokinetics Corporation
$ 0.0602
(0.50%)
8.33M
JAGXJaguar Health Inc
$ 0.0853
(-5.12%)
3.87M
GMDAGamida Cell Ltd
$ 0.04
(10.80%)
3.76M
AAPLApple Inc
$ 171.25
(-0.13%)
3.58M

PYXS Discussion

View Posts
Awl416 Awl416 1 month ago
Pyxis Oncology Announces $50 Million Private Placement
πŸ‘οΈ0
euroconversions euroconversions 7 months ago
Insiders buying, always a good sign.
PYXS Long
πŸ‘οΈ0
jack7377 jack7377 11 months ago
PYSX#$$: Hey Bulba and JuneBugs , this Log Legged Loin Puppy is getting ready to Break it's Chain,Leap and go on an Epic Run North. Friday's 1st Qtr Financials are going to make this spring 200-300%.
πŸ‘οΈ0
TheFinalCD TheFinalCD 12 months ago
I did, nice P&D

https://www.tiktok.com/@stockdads/video/7217125391520091434
πŸ‘οΈ0
SpaceTimeRift777 SpaceTimeRift777 12 months ago
Wouldn't touch it until we see if that $3 support can hold
GL
πŸ‘οΈ0
spencer22 spencer22 12 months ago
Perfect example of dilution,in other words a classic pump and dump in my opinion!
👍️ 1
0210 0210 12 months ago
7). $10.75 PYXS Target Price @ Fin Viz.

8). BUY Rating $14.00 PYXS PT @ Market Beat.

9). $10.75 PT +++Positive+++ Short, Medium and Long Term Performance Outlook, Yahoo Finance.

10). BUY Rating @Reuters.
πŸ‘οΈ0
0210 0210 12 months ago
buyin' dips $4.00 - $4.10. 14m BUYs (+5m?) vs. 12m Sells this Friday. hmmm.....

1). 88% Buy, up from 72% buy last week and 40% Buy, a month ago @Barchart.

2). Stay Long @ American Bulls.

3). $10.75 Price Target, from 5 analysts @Barrons.

4). $4.00 >$11.50 > $16.00 Price Targets @CNN Business.

5). HOLD Rating @ Zacks.

6). $11.22 TP mean rating, Chartmill.
πŸ‘οΈ0
interloper interloper 12 months ago
I just heard the same thing from a cousin who said it was on Reddit.
πŸ‘οΈ0
Jess070283 Jess070283 12 months ago
That dip was a gift. Loaded way oversold.
πŸ‘οΈ0
magacrew2020 magacrew2020 12 months ago
potential halt at $2. seems to be fair value
πŸ‘οΈ0
da_stock_analyst da_stock_analyst 12 months ago
#PYXS ?? big squeeze coming??!! Attractive bullish chart! $PYXS
πŸ‘οΈ0
Pyramid2 Pyramid2 12 months ago
* * > $7 halt < * *

Went short $6.85 and they halted it $6.92 and she dropped. I thought not again just like SVIBQ and it will open 2 weeks later at $100. I am still waiting to get my trading groove back. This thing has been a rocket from $3.92 yesterday. No position now closed out on $6 close.

glta.
πŸ‘οΈ0
SpaceTimeRift777 SpaceTimeRift777 12 months ago
Better lock profits today this will come back down to earth

Way Overbought
πŸ‘οΈ0
SpaceTimeRift777 SpaceTimeRift777 12 months ago
One hell of a Moon Market pump
πŸ‘οΈ0
jakec21 jakec21 12 months ago
Please post something that you have proof. You r on my radar alert
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 12 months ago
PYXS....MONSTER TAKING OFF!!
πŸ‘οΈ0
PickItToWin PickItToWin 12 months ago
Thorough DD is how I found my info and jumped in at $2. Definitely happy with my ROI this week, hope others took advantaged as well. GLTA
πŸ‘οΈ0
eastunder eastunder 12 months ago
It's from a tiktok video...

Where all valid information comes from.
πŸ‘οΈ0
da_stock_analyst da_stock_analyst 1 year ago
#PYXS ?? can it double from here? very bullish chart! see the video $PYXS
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
hmmmm, any info or articles to back your post up?


Message in reply to:
Target price is $12-$16. Nancy Pelosi’s husband just scooped up a bunch of PYXS and he somehow always has the inside scoop on stocks ;)
πŸ‘οΈ0
Jess070283 Jess070283 1 year ago
Beast!$$$
πŸ‘οΈ0
Randyfloyd420 Randyfloyd420 1 year ago
Yea what a joke
πŸ‘οΈ0
eastunder eastunder 1 year ago
I did. There is nothing that I found that backed that up.

So if you have something, cam you please post a link?

I really am curious.

I don't see Pelosi buying something like this.

Why?
πŸ‘οΈ0
PickItToWin PickItToWin 1 year ago
Just do a Google search on Pyxs and Nancy Pelosi. She’s not the only one buying it up.
πŸ‘οΈ0
eastunder eastunder 1 year ago
How do you know that?
πŸ‘οΈ0
PickItToWin PickItToWin 1 year ago
Target price is $12-$16. Nancy Pelosi’s husband just scooped up a bunch of PYXS and he somehow always has the inside scoop on stocks ;)
πŸ‘οΈ0
Amatuer17 Amatuer17 1 year ago
Seems an interesting play in ADC
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock